$6.6 bn herpes simplex virus infections markets - global strategic business report to 2030 with coverage of 10+ major players including admedus, agenus, and aicuris anti-infective cures

Dublin, july 19, 2024 (globe newswire) -- the "herpes simplex virus infections - global strategic business report" report has been added to researchandmarkets.com's offering. the global market for herpes simplex virus infections is estimated at us$5.0 billion in 2023 and is projected to reach us$6.6 billion by 2030, growing at a cagr of 4.0% from 2023 to 2030. this comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. the growth in the hsv infections treatment market is driven by several factors. technological advancements in antiviral drug formulations are enhancing the effectiveness and convenience of treatments, making them more accessible to a broader patient population. the rising prevalence of hsv infections worldwide, coupled with increasing awareness and diagnosis rates, is expanding the demand for effective management solutions. consumer behavior trends towards proactive health management and the demand for convenient, over-the-counter treatment options are also contributing to market growth.
AGEN Ratings Summary
AGEN Quant Ranking